Funding for this research was provided by:
The Royal Dutch Pharmacist's Association, The Hague (KNMP), The Netherlands (-)
Zorg & Zekerheid, Leiden, The Netherlands. (-)
Text and Data Mining valid from 2019-06-14
Received: 2 December 2018
Accepted: 8 May 2019
First Online: 14 June 2019
Ethics approval and consent to participate
: The central Medical Ethics Review board of the Leiden University Medical Center (LUMC) in Leiden, The Netherlands, approved the protocol of the IP3 study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.